Medial temporal atrophy predicts the limbic comorbidities in lewy body disease

Keita Sakurai1, Daita Kaneda2, Satoru Morimoto3

  • 1Department of Radiology, National Center for Geriatrics and Gerontology, 7-430 Morioka-Cho, Obu, Aichi, 474-8511, Japan. ksak666@yahoo.co.jp.

Neuroradiology
|November 12, 2024
PubMed
Abstract

Insights

Magnetic resonance imaging (MRI) indices of medial temporal atrophy can help differentiate pure Lewy body disease (LBD) from mixed LBD with Alzheimer's disease neuropathological change (AD-NC) or limbic-predominant age-related TAR DNA-binding protein 43encephalopathy neuropathological change (LATE-NC). These MRI findings correlate with AD-NC severity and aid in diagnosing LBD comorbidities.

Area of Science:

  • Neurology
  • Radiology
  • Pathology

Background:

  • Lewy body disease (LBD) often co-occurs with Alzheimer's disease neuropathological change (AD-NC) and limbic-predominant age-related TAR DNA-binding protein 43encephalopathy neuropathological change (LATE-NC).
  • Medial temporal atrophy is associated with these comorbidities in LBD, but the diagnostic utility of MRI is not well-established.

Purpose of the Study:

  • To evaluate the diagnostic performance of MRI-derived medial temporal atrophy indices in distinguishing between pure LBD and mixed LBD (mLBD) with AD-NC and/or LATE-NC.

Main Methods:

  • Included 24 pathologically confirmed mLBD and 16 pure LBD patients.
  • Assessed medial temporal atrophy using entorhinal cortex atrophy (ERICA) scores and cross-sectional areas of entorhinal cortices/parahippocampal gyri (ABEP).

Main Results:

  • ABEP and ERICA scores showed significant diagnostic performance in differentiating mLBD from pure LBD (AUC 0.87 and 0.80, respectively).
  • ABEP demonstrated high diagnostic performance (AUC 0.94) in distinguishing pure LBD from mLBD with both AD-NC and LATE-NC.
  • MRI indices, particularly ABEP, correlated with AD-NC severity and showed a trend with LATE-NC.

Conclusions:

  • Medial temporal atrophy on MRI is a valuable tool for diagnosing comorbidities in pathologically confirmed LBD.
  • MRI-derived indices effectively differentiate LBD subtypes based on the presence of AD-NC and LATE-NC.

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
448
Functional Brain Systems: Limbic System01:15

Functional Brain Systems: Limbic System

The limbic system, often called the "emotional brain," is a complex set of structures located deep within the brain. The intricate network of the limbic system supports a wide range of psychological functions, from emotional regulation to memory formation and sensory processing. This functional brain region encompasses specific parts of the diencephalon and the cerebrum, integrating the higher mental functions of the cerebral cortex with the primitive emotional responses of the deep...
2.3K
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
97
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
482
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K